MedAvail Holdings Inc Watch

from S-3 39 pages MedAvail Holdings, Inc. $50,000,000 Common Stock Sales Agreement

from SC 13G/A 1 page Joint Filing Statement Statement Pursuant to Rule 13d-1

from SC 13D 2 pages Joint Filing Agreement

from SC 13G 1 page Joint Filing Statement Statement Pursuant to Rule 13d-1

from 8-K 5 pages This Letter (The “Agreement”) Constitutes the Agreement Between MYOS Corporation (The “Company”) and Chardan Capital Markets, LLC (“Chardan”) That Chardan Shall Serve as the Exclusive Placement Agent (The “Services”) for the Company, on a Reasonable Best Efforts Basis, in Connection With the Proposed Offer and Placement (The “Offering”) by the Company of Securities of the Company (The “Securities”). the Terms of the Offering and the Securities Shall Be Mutually Agreed Upon by the Company and the Investors and Nothing Herein Implies That Chardan Would Have the Power or Authority to Bind the Company or an Obligation for the Company to Issue Any Securities or Complete the Offering. the Company Expressly Acknowledges and Agrees That the Execution of This Agreement Does Not Constitute a Commitment by Chardan to Purchase the Securities and Does Not Ensure the Successful Placement of the Securities or Any Portion Thereof or the Success of Chardan With Respect to Securing Any Other Financing on Behalf of the Company. the Parties Agree That the Services Shall Include Access to All of Chardan’s Resources. A. Fees and Expenses. in Connection With the Services Described Above, the Company Shall Pay to Chardan the Following Compensation: 1. Placement Agent’s Fee. the Company Shall Pay to Chardan a Cash Placement Fee Equal to 7% of the Aggregate Purchase Price Paid by Each Purchaser of Securities That Are Placed in the Offering

from 8-K 6 pages Strictly Confidential